Clinical use of biomarkers of survival in pulmonary fibrosis

BACKGROUND: Biologic predictors or biomarkers of survival in pulmonary fibrosis with a worse prognosis, more specifically in idiopathic pulmonary fibrosis would help the clinician in deciding whether or not to treat since treatment carries a potential risk for adverse events. These decisions are mad...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomeer, Michiel, Grutters, Jan C, Wuyts, Wim A, Willems, Stijn, Demedts, Maurits G
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907324/
https://www.ncbi.nlm.nih.gov/pubmed/20584284
http://dx.doi.org/10.1186/1465-9921-11-89

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907324/
https://www.ncbi.nlm.nih.gov/pubmed/20584284
http://dx.doi.org/10.1186/1465-9921-11-89

Ejemplares similares